International Liver Congress™ 2022 rescheduled to 22–26 June 2022
Savour science in the summer, together again, in London Message from EASL Secretary General, Prof. Thomas Berg. Dear friends, As governments across the world restrict travel and large-scale gatherings, the EASL Governing Board expresses solidarity with all efforts to mitigate…
EASL events in February 2022 transition to being fully online
20 December 2021 This is an important announcement for our community engaged in fighting liver cancer and viral hepatitis. Given the current and evolving constraints and uncertainty triggered by COVID-19, the EASL Governing Board has decided that two events scheduled…
EASL’s Patient Forum 2021 highlights health literacy to empower patients and address inequities
20 December 2021 On 22 November 2021, EASL held its annual Patient Forum on the topic: health literacy to empower patients and address inequities. We collaborated with five members of our Patient Synergies network to bring together the expertise of…
The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe
The EASL–Lancet Liver Commission calls for a paradigm shift in the liver disease response in Europe: prevention and early detection, not end-stage treatment of complications. Liver disease is now the second leading cause of years of working life lost in…
Engaging high-level advocacy activities mark October as Liver Cancer Awareness month
9 November 2021 With October being a month dedicated to promoting liver cancer awareness, EASL participated in numerous relevant activities. EASL leadership played a key role notably in two high-level advocacy events, coming to the heart of advocacy. The European…
Announcing an EASL webinar on managing NAFLD, dedicated to nurses and Allied Health Professionals
EASL’s engagement with nurses and Allied Health Professionals (AHPs) has been thriving through 2021. Their next contribution for the global liver community is a webinar by the EASL Nurses and AHPs Task Force in which they will be sharing their expertise on managing NAFLD in patients. …
Experts to showcase cutting-edge research at flagship hepatology congress
EASL’s International Liver Congress™ (ILC) 2022 will be taking place in London, UK, 22–26 June 2022. Delegates can attend in person or remotely. This first-in-class, international event is running for the 57th time and is the largest annual event on…
EASL supports the “Gift of Life”
Together with 21 international medical societies EASL strongly reaffirms the essential values held by the global community of transplant providers. We stand against any form of barriers in access, knowledge, transition and required training around organ donation. We back the…
EASL makes a statement for the liver at 71st Session of the WHO Regional Committee for Europe
17 September 2021 On 14 September 2021, EASL, in its role as non-state actor in official relations with the World Health Organization (WHO), provided a joint statement on matters of considerable importance in liver care: primary health care and keeping viral hepatitis elimination clearly on the agenda.